Episode description
Episode description
Join our guest Prof David Rees and host Dr Christian Scharenberg as they discuss how the concept of precision medicine can be applied to Sickle Cell Disease (SCD).
Listen as Prof David Rees talks about prognostic markers and how they can (or can't) guide SCD disease management, current and new treatment options for SCD patients, and how the situation of precision medicine can differ between low- and high-income countries. Last but not least, Prof David Rees ends the podcast with his view of how SCD management will be in the near and far future.
This discussion is based on a recently published article, Precision Medicine and Sickle Cell Disease by Prof David Rees, in Hemasphere. This is the first of a series of podcasts discussing recently published articles. More podcasts in this series will be available in the future. Stay tuned!
Visit the EHA Campus for more content on Hemoglobinopathies and Sickle Cell Disease:
1. EHA Sickle cell disease program
2. EHA Unplugged Sickle Cell Disease podcast series (Available on all major podcast platforms and on the EHA Campus)
3. Gene Therapy in Hemoglobinopathies
Host: Dr Christian Scharenberg, Skaraborgs Hospital, Sweden; Guest: Professor David Rees, Kings College London, United Kingdom
What did you think of this podcast? Share your opinion with us in this short feedback survey.
Would you like to explore more eLearning or podcasts? Please visit the EHA Campus.
Subscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to.
Follow EHA on Instagram: https://www.instagram.com/EHA_Hematology/
Facebook: https://e-h-a.link/facebook
LinkedIn: https://www.linkedin.com/company/eha/
Email us: education@ehaweb.org
Subscribe to receive the EHA Educational Updates via https://eha.news/subscribe